Showing results (301-310 of 330) with videos related to
Sort By:
Pageof 33
Hamostaseologie|May 1, 2009
[Relevance of a single dose of 270 microg/kg recombinant factor VIIa for the treatment of patients with haemophilia and inhibitors - Recommendations from the GTH experts]Günter Auerswald, W Muntean, B Kemkes-Matthes, et al.Hamostaseologie|November 6, 2010
Molecular analysis of FVIII gene in severe HA patients of Costa RicaL Salazar-Sánchez, G Jiménez-Cruz, M Mendez, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|July 13, 2006
Sequencing of the factor 8(F8) coding regions in 10 Turkish hemophilia A patients reveals three novel pathological mutations, and one rediagnosis of von Willebrand's disease type 2NE Berber, I D Fidanci, C Un, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|August 29, 2015
Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq® ) in adults with severe haemophilia A: efficacy and safetyT Lissitchkov, K Hampton, M von Depka, et al.Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII geneO El-Maarri, U Herbiniaux, J Graw, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and AustriaH Pollmann, D Externest, A Ganser, et al.Scientific Reports|February 24, 2019
Transcriptome-wide analysis of filarial extract-primed human monocytes reveal changes in LPS-induced PTX3 expression levelsB C Buerfent, L Gölz, A Hofmann, et al.European Journal of Medical Research|April 14, 2011
Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetenceM Vogel, O Friedrich, G Lüchters, et al.Clinical Orthopaedics and Related Research|July 1, 1985
Bioresorption of ceramic strontium-85-labeled calcium phosphate implants in dog femora. A pilot study to quantitate bioresorption of ceramic implants of hydroxyapatite and tricalcium orthophosphate in vivoW Renooij, H A Hoogendoorn, W J Visser, et al.Thrombosis and Haemostasis|April 20, 2001
Genetic predisposition to bleeding during oral anticoagulant therapy: evidence for common founder mutations (FIXVal-10 and FIXThr-10) and an independent CpG hotspot mutation (FIXThr-10)J Oldenburg, K Kriz, W A Wuillemin, et al.Pageof 33